{"id":"doi:10.1212/wnl.0000000000209218","kind":"article","title":"Cost-Effectiveness of Lecanemab for Individuals With Early-Stage Alzheimer Disease","authors":["Hai V. Nguyen","Shweta Mital","David S. Knopman","G. Caleb Alexander"],"author_count":4,"year":2024,"published":"2024-03-14","venue":"Neurology","cited_by":82,"doi":"10.1212/wnl.0000000000209218","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1212/wnl.0000000000209218","archive_url":"https://space-kitty.com/papers/doi:10.1212/wnl.0000000000209218","updated":null,"pmid":"38484190","pmcid":null,"openalex_id":"W4392795292","pdf_url":null,"abstract":null,"abstract_license":null,"license":null,"is_open_access":false,"retracted":false,"peer_reviewed":null,"categories":["Health Systems, Economic Evaluations, Quality of Life"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"neurodegeneration","name":"Alzheimer's, Parkinson's & Neurodegeneration","domain_slug":"medicine"}],"cited_in_dossiers":[]}